Dextech has filed a new patent application regarding GMP production (Good Manufacturing Practice) of the company's lead candidate OsteoDex with the European Patent Office (EPO.Org). The application describes a GMP synthesis method on a larger scale that results in a pharmaceutical-grade product as well as OsteoDex use for the treatment of cancer that develops in the bones.
The application is of great importance for the Company's planned clinical further development of OsteoDex (phase 3, castration-resistant prostate cancer) together with a major partner.
"- A synthesis patent will have a strong positive impact on our ability to secure OsteoDex's resource-intensive continued clinical development. The patent protection will extend until about 2044 and I see the conditions for a granted patent as very good," says CEO
For more information about DexTech, please contact:
Phone: +46 (0) 707104788
E-mail: gosta.lundgren@dextechmedical.com
This information is information that
https://news.cision.com/dextech/r/dextech-medical-files-a-new-patent-application-with-the-european-patent-office,c3853506
https://mb.cision.com/Main/11652/3853506/2358495.pdf
(c) 2023 Cision. All rights reserved., source